Position in NVO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$700,786
+$165,412 QoQ
Shares Held
14,618
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#617
of 1,348 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLAND CAPITAL MANAGEMENT, LLC holds $74,462,523 across 8 Drug Manufacturers - General names. NVO ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
233,452 | $29,998,582 | |
| 2 | JNJ |
Johnson & Johnson
|
62,572 | $15,891,410 | |
| 3 | LLY |
ELI LILLY & Co
|
10,931 | $13,110,970 | |
| 4 | ABBV |
AbbVie Inc.
|
43,576 | $10,965,464 | |
| 5 | NVS |
Novartis AG
|
13,845 | $2,169,788 | |
| 6 | GSK |
GSK plc
|
16,642 | $872,373 | |
| 7 | PFE |
Pfizer Inc
|
31,277 | $753,150 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
14,618 | $700,786 |
All Filings in NVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $700,786 | 14,618 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $535,374 | 14,568 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $737,760 | 14,500 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $898,938 | 16,200 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,135,379 | 16,450 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,135,344 | 16,350 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,419,330 | 16,500 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,488,375 | 12,500 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||